[go: up one dir, main page]

FR2840921B1 - Procede de culture in vitro du virus vhc - Google Patents

Procede de culture in vitro du virus vhc

Info

Publication number
FR2840921B1
FR2840921B1 FR0207600A FR0207600A FR2840921B1 FR 2840921 B1 FR2840921 B1 FR 2840921B1 FR 0207600 A FR0207600 A FR 0207600A FR 0207600 A FR0207600 A FR 0207600A FR 2840921 B1 FR2840921 B1 FR 2840921B1
Authority
FR
France
Prior art keywords
vitro culture
hcv virus
hcv
virus
vitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0207600A
Other languages
English (en)
Other versions
FR2840921A1 (fr
Inventor
Patrice Andre
Pradel Florence Komurian
Vincent Lotteau
Baccala Glaucia Parnahos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Biomerieux SA
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0207600A priority Critical patent/FR2840921B1/fr
Application filed by Biomerieux SA, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Biomerieux SA
Priority to CNB038140926A priority patent/CN100500836C/zh
Priority to AU2003260593A priority patent/AU2003260593A1/en
Priority to PCT/FR2003/001820 priority patent/WO2003106665A1/fr
Priority to EP03760045A priority patent/EP1513930A1/fr
Priority to JP2004513478A priority patent/JP2006500918A/ja
Priority to US10/515,381 priority patent/US20050221464A1/en
Publication of FR2840921A1 publication Critical patent/FR2840921A1/fr
Application granted granted Critical
Publication of FR2840921B1 publication Critical patent/FR2840921B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24251—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0207600A 2002-06-18 2002-06-18 Procede de culture in vitro du virus vhc Expired - Fee Related FR2840921B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0207600A FR2840921B1 (fr) 2002-06-18 2002-06-18 Procede de culture in vitro du virus vhc
AU2003260593A AU2003260593A1 (en) 2002-06-18 2003-06-16 Method for culturing hvc virus in vitro
PCT/FR2003/001820 WO2003106665A1 (fr) 2002-06-18 2003-06-16 Procede de culture in vitro du virus vhc
EP03760045A EP1513930A1 (fr) 2002-06-18 2003-06-16 Procede de culture in vitro du virus vhc
CNB038140926A CN100500836C (zh) 2002-06-18 2003-06-16 Hcv病毒体外培养方法
JP2004513478A JP2006500918A (ja) 2002-06-18 2003-06-16 ｉｎｖｉｔｒｏにおけるＨＣＶウイルスの培養方法
US10/515,381 US20050221464A1 (en) 2002-06-18 2003-06-16 Method for culturing hcv virus in vitro

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0207600A FR2840921B1 (fr) 2002-06-18 2002-06-18 Procede de culture in vitro du virus vhc

Publications (2)

Publication Number Publication Date
FR2840921A1 FR2840921A1 (fr) 2003-12-19
FR2840921B1 true FR2840921B1 (fr) 2008-07-18

Family

ID=29595374

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0207600A Expired - Fee Related FR2840921B1 (fr) 2002-06-18 2002-06-18 Procede de culture in vitro du virus vhc

Country Status (7)

Country Link
US (1) US20050221464A1 (fr)
EP (1) EP1513930A1 (fr)
JP (1) JP2006500918A (fr)
CN (1) CN100500836C (fr)
AU (1) AU2003260593A1 (fr)
FR (1) FR2840921B1 (fr)
WO (1) WO2003106665A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1886685A1 (fr) * 2006-08-11 2008-02-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Méthodes, utilisations et compositions pour la modulation de la réplication du HCV par activation ou inhibition du récepteur farnesoid X
US7645732B2 (en) * 2007-01-24 2010-01-12 Board Of Regents, The University Of Texas System Treating hepatitis C virus infection
WO2008124384A2 (fr) * 2007-04-03 2008-10-16 Aegerion Pharmaceuticals, Inc. Méthodes de traitement de l'hépatite c

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796962B1 (fr) * 1999-07-30 2003-11-21 Bio Merieux Procede de culture in vitro de virus des familles togaviridae et flaviviridae, lignee cellulaire et utilisations
FR2812304B1 (fr) * 2000-07-31 2004-12-17 Bio Merieux Complexe de lipo-viro-particules, procede de preparation et applications

Also Published As

Publication number Publication date
CN1662646A (zh) 2005-08-31
JP2006500918A (ja) 2006-01-12
WO2003106665A1 (fr) 2003-12-24
AU2003260593A8 (en) 2003-12-31
US20050221464A1 (en) 2005-10-06
FR2840921A1 (fr) 2003-12-19
AU2003260593A1 (en) 2003-12-31
EP1513930A1 (fr) 2005-03-16
CN100500836C (zh) 2009-06-17

Similar Documents

Publication Publication Date Title
NO20042159L (no) Cellokulturprosess
DE60308093D1 (de) Zellkultivierungsvorrichtung und diese benutzende Verfahren zur Zellsortierung
EP1596427A4 (fr) Procede d'introduction d'impuretes
FR2871167B1 (fr) Procede d'amelioration de coupes essences et de transformation en gazoles
EP1517991A4 (fr) Procede de transformation du soja
FR2860224B1 (fr) Solide cristallise im-12 et son procede de preparation
FR2868414B1 (fr) Procede de production d'alpha-alumine particulaire et apha-alumine particulaire produite par ce procede
EP1506965A4 (fr) Derives de propanolamine, procede de preparation de 3-n-methylamino-1-(2-thienyl)-1-propanols et procede de preparation de derives de propanolamine
EE200400107A (et) Protsess kõrgpuhta perindopriili ning sünteesis kasulike vaheühendite valmistamiseks
AU2003290842A8 (en) Process for designing inhibitors of influenza virus non-structural protein 1
AU2003296819A1 (en) Molecules inhibiting hepatitis c virus protein synthesis and method for screening same
FR2840921B1 (fr) Procede de culture in vitro du virus vhc
ITTO20030566A1 (it) Procedimento di ottimizzazione e sincronizzazione di processi
FR2852012B1 (fr) Procede de preparation de derives o-acyles du glucose
EP1954271A4 (fr) Procede de preparation de pyridinamines et nouveaux polymorphes associes
FR2866245B1 (fr) Nouveaux agents epaississants et leur procede de preparation
EP1745132A4 (fr) Procede de transformation et regeneration hautement efficaces de cultures vegetales en suspension
EP1285961A4 (fr) Procede de formation in vitro de pancreas de vertebre
EP1518598A4 (fr) Procede d'epuration de gaz d'echappement
MA29005B1 (fr) Nouveaux procede et intermediaires de preparation de derives de n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulfonamide
FR2843743B1 (fr) PROCEDE DE FABRICATION DE SO2F2 ET DE SO2ClF
NO20041633L (no) Fremgangsmate for fremstilling av heparin fra mastcelle kulturer
EP1682627A4 (fr) Procede de preparation de methyllithium
EP1756036A4 (fr) Derives indenes et leur procede d'elaboration
NO20015285D0 (no) Fremstillingsprosess for n¶ringsmiddelfermenterende midler

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20110228